Protealis SA
17.2 FTEThe score of Protealis shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +38 % Headcount (avg FTE) +182 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Protealis's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 27 May 2025
- Year ended 31 Dec 2023filed on 29 May 2024
- Year ended 31 Dec 2022filed on 11 May 2023
Protealis's financial analysis
- Solvency81.5%sector median: 61.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Protealis
Protealis's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.251.410
- VAT number
- BE0765251410
- Peppol
- Registered · 0208:0765251410 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 16 Mar 2021
- Registered office
- 9052 Ghent
- Size
- Small · 17.2 FTE
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Protealis (SA) has been based in Ghent since 2021, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €4.98m and equity of €9.06m; its revenue is not published. With 17.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 81.5%, above the median of its sector (61.7%).
Companies similar to Protealis
Companies in the same business, of comparable size and area, outside its group.
- Biotalys Research and experimental development on natural sciences and engineering Ghent · balance sheet €16.3m
- Fyteko Research and experimental development on natural sciences and engineering Anderlecht · balance sheet €11.7m
- AstriVax Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €12.5m
- EXO Biologics Research and experimental development on natural sciences and engineering Liège · balance sheet €11.7m
- Microbial Resource Management Health Research and experimental development on natural sciences and engineering Ghent · balance sheet €11.7m
- The Akkermansia Company Research and experimental development on natural sciences and engineering Mont-Saint-Guibert · balance sheet €16.9m
- Intrexon Actobiotics Research and experimental development on natural sciences and engineering Nazareth-De Pinte · balance sheet €8.76m
- ConvEyXo Research and experimental development on natural sciences and engineering Charleroi · balance sheet €10.3m
Frequently asked questions about Protealis
What is the revenue of Protealis?
Protealis files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Protealis?
In Belgium, the VAT number is the company number prefixed with BE: BE0765251410 for Protealis, if the company is VAT-registered. Its company number (CBE) is 0765.251.410.
Where is the registered office of Protealis?
According to the CBE register, the registered office of Protealis is in 9052 Ghent.
What is the equity of Protealis?
At the close of the 2025 financial year, the equity of Protealis amounts to 9,062,218 €, a solvency of 81.5% of total assets.
How many people work at Protealis?
17.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Protealis?
The register lists 15 active mandates at Protealis. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Protealis
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →